2015
DOI: 10.1016/j.ejmech.2015.06.013
|View full text |Cite
|
Sign up to set email alerts
|

Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: Synthesis, biological evaluation and molecular modeling studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 29 publications
1
27
0
Order By: Relevance
“…5-arylidenehydantoins (Handzlik et al, 2013;Spengler et al, 2010) or 5-arylideneimidzol-4-ones (Bohnert et al, 2016), are a very promising group. These compounds are able to block MDR efflux pumps (Amaral et al, 2012) or act as adjuvants of antibiotics also via other mechanisms (Matys et al, 2015). The results of our previous studies indicate that both efflux pump inhibitory potency and pump specificity were significantly affected by the presence and position of a piperazine moiety within the molecules.…”
Section: Introductionmentioning
confidence: 63%
See 1 more Smart Citation
“…5-arylidenehydantoins (Handzlik et al, 2013;Spengler et al, 2010) or 5-arylideneimidzol-4-ones (Bohnert et al, 2016), are a very promising group. These compounds are able to block MDR efflux pumps (Amaral et al, 2012) or act as adjuvants of antibiotics also via other mechanisms (Matys et al, 2015). The results of our previous studies indicate that both efflux pump inhibitory potency and pump specificity were significantly affected by the presence and position of a piperazine moiety within the molecules.…”
Section: Introductionmentioning
confidence: 63%
“…However, much better properties with regard to adjuvants of antibiotics were achieved with the introduction of the piperazine substituent at the 2-position converting, along the way, imidazolidine-2,4-dione into imidazole-4-one [(3) and (4) in Fig. 1] (Bohnert et al, 2016;Matys et al, 2015). Thus, the last group [(3) and 4], represented also by compounds (5) and (6) ( Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Hydantoin derivatives used in the pharmacological assays were obtained by chemical synthesis. The new generations IIIA and B were obtained using 3–4-step synthesis ( Handzlik et al, 2014 ; Matys et al, 2015 ; Figure 1 and Supplementary data). Purity and identity of new compounds were confirmed using spectral analysis (H-NMR, IR), elemental analysis and melting point measurements.…”
Section: Methodsmentioning
confidence: 99%
“…vants of -lactam antibiotics (oxacillin and cloxacillin) against S. aureus strains (HEMSA), the highly problematic Grampositive bacteria in clinical treatment (Matys et al, 2015). Both actions are very promising for a new therapeutic approach to the treatment of bacterial infections.…”
Section: Figurementioning
confidence: 99%
“…1b], but a series of more promising agents was found in the group of 5-arylidene-substituted hydantoins, modification pathway (II), with piperazine at position 3 [(2); Fig. 1b] (Handzlik et al, 2012) strongly improved the activity (Bohnert et al, 2016;Matys et al, 2015). Further modifications in order to change the imidazolidine-2,4-dione core into 3H-imidazol-4(5H)-one [modification pathway (III); Fig.…”
Section: Introductionmentioning
confidence: 99%